Naoki Watanabe

1.5k total citations
36 papers, 318 citations indexed

About

Naoki Watanabe is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Naoki Watanabe has authored 36 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 7 papers in Surgery. Recurrent topics in Naoki Watanabe's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Medical Imaging and Pathology Studies (5 papers). Naoki Watanabe is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Medical Imaging and Pathology Studies (5 papers). Naoki Watanabe collaborates with scholars based in Japan, Italy and Libya. Naoki Watanabe's co-authors include Nobuhiro Kanaji, Norimitsu Kadowaki, Shuji Bandoh, Tomoya Ishii, Nobuyuki Kita, Takehiro Takagi, Reiji Haba, Yasunori Tojo, Osamu Imataki and Hiroyasu Yokomise and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and Cancers.

In The Last Decade

Naoki Watanabe

32 papers receiving 315 citations

Peers

Naoki Watanabe
Byron E. Crawford United States
Yael Aschner United States
Seok-Chul Yang South Korea
Woo Ik Yang South Korea
Kai Mi China
Naoki Watanabe
Citations per year, relative to Naoki Watanabe Naoki Watanabe (= 1×) peers R. Vergés

Countries citing papers authored by Naoki Watanabe

Since Specialization
Citations

This map shows the geographic impact of Naoki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Watanabe more than expected).

Fields of papers citing papers by Naoki Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Watanabe. The network helps show where Naoki Watanabe may publish in the future.

Co-authorship network of co-authors of Naoki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Watanabe. A scholar is included among the top collaborators of Naoki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Watanabe. Naoki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Takuya, Nobuhiro Kanaji, Takafumi Nakamura, et al.. (2025). Antitumor Effects of Combination Therapy with Oncolytic Vaccinia Virus and Tepotinib on Lung Cancer Cells. Cancers. 17(16). 2681–2681.
2.
Kanaji, Nobuhiro, et al.. (2025). Immune Checkpoint Inhibitor-Induced Insidiously Progressive, Fatal Interstitial Lung Disease. Journal of Personalized Medicine. 15(3). 115–115. 1 indexed citations
3.
Kokubo, Yoshihiro, Mai Inoue, Attayeb Mohsen, et al.. (2025). Machine Learning Model for Predicting Coronary Heart Disease Risk: Development and Validation Using Insights From a Japanese Population–Based Study. JMIR Cardio. 9. e68066–e68066. 6 indexed citations
4.
Watanabe, Naoki, Ai Sato, Yutaka Tanaka, et al.. (2024). Chromosomal Abnormalities as a Predisposition to Secondary Neurolymphomatosis in Patients with Diffuse Large B-Cell Lymphoma: A Report of Two Cases and a Literature Review. SHILAP Revista de lepidopterología. 17(1). 1201–1207. 1 indexed citations
5.
Kanaji, Nobuhiro, et al.. (2023). Superior vena cava syndrome induced by lung hyperinflation in chronic obstructive pulmonary disease: a case report. Journal of Medical Case Reports. 17(1). 497–497.
6.
Watanabe, Naoki, Mayumi Ito, Shiho Iwagaitsu, et al.. (2022). A case of 2,8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment. CEN Case Reports. 12(3). 329–334. 3 indexed citations
7.
Kanaji, Nobuhiro, Kyuichi Kadota, Takuya Inoue, et al.. (2019). Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients. The Open Respiratory Medicine Journal. 13(1). 31–38. 4 indexed citations
8.
Kanaji, Nobuhiro, et al.. (2019). Characteristics of multiple nodules in a patient with pulmonary Langerhans cell histiocytosis: A case report. World Journal of Clinical Cases. 7(17). 2519–2525. 2 indexed citations
9.
Kanaji, Nobuhiro, et al.. (2019). Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer. Respiratory Investigation. 57(5). 472–480. 6 indexed citations
10.
Kanaji, Nobuhiro, Takuya Inoue, Naoki Watanabe, et al.. (2018). Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation. Therapeutics and Clinical Risk Management. Volume 14. 1361–1368. 13 indexed citations
11.
Watanabe, Naoki, Tomoya Ishii, Nobuyuki Kita, et al.. (2018). The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions. BMC Pulmonary Medicine. 18(1). 176–176. 15 indexed citations
12.
Kanaji, Nobuhiro, Masanao Yokohira, Naoki Watanabe, Norimitsu Kadowaki, & Shuji Bandoh. (2018). Transforming Growth Factor-Beta Produced by Non-small Cell Lung Cancer Cells Contributes to Lung Fibroblast Contractile Phenotype. Anticancer Research. 38(4). 2007–2014. 6 indexed citations
13.
Watanabe, Naoki, Shuji Bandoh, Tomoya Ishii, et al.. (2017). Infective endocarditis and infected aneurysm caused by Streptococcus dysgalactiae subsp. equisimilis : a case report. Clinical Case Reports. 5(2). 187–192. 8 indexed citations
14.
Watanabe, Naoki, Kiyofumi Ohkusu, Osamu Imataki, et al.. (2017). Phanerochaete sordida as a cause of pulmonary nodule in an immunocompromised patient: a case report. BMC Infectious Diseases. 17(1). 135–135. 6 indexed citations
15.
Kanaji, Nobuhiro, Kenichiro Sakai, Yutaka Ueda, et al.. (2017). Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease. Lung Cancer. 108. 126–133. 20 indexed citations
16.
Kanaji, Nobuhiro, Masanao Yokohira, Naoki Watanabe, et al.. (2017). Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression. Respiratory Research. 18(1). 118–118. 26 indexed citations
17.
Kanaji, Nobuhiro, Koichí Matsumoto, Tomoya Ishii, et al.. (2016). An Uncharted Constellation: TAFRO Syndrome. The American Journal of Medicine. 129(9). 938–941. 13 indexed citations
18.
Ishii, Tomoya, Takayuki Takahama, Naoki Watanabe, et al.. (2013). Paraneoplastic Focal Segmental Glomerulosclerosis in a Patient with Lung Adenocarcinoma. Internal Medicine. 52(17). 1953–1956. 4 indexed citations
19.
Watanabe, Naoki, et al.. (2009). A case of multiple intrapulmonary lymph nodes with interstitial pneumonia. The Journal of the Japanese Association for Chest Surgery. 23(6). 886–890. 1 indexed citations
20.
Uetsuka, Hirokazu, et al.. (1997). A Case of Malignant Asymptomatic Pancreatic Endocrinoma with Extrapancreatic Growth.. The Japanese Journal of Gastroenterological Surgery. 30(9). 1942–1946. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026